Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions. - Wikidata - awgldk - TriplyDB

Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions.

Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions.

http://www.wikidata.org/entity/Q33982878

about

Potential Effects of Pomegranate Polyphenols in Cancer Prevention and Therapy Pomegranate fruit as a rich source of biologically active compounds Potent anti-proliferative, pro-apoptotic activity of the Maytenus royleanus extract against prostate cancer cells: evidence in in-vitro and in-vivo models Role of traditional Islamic and Arabic plants in cancer therapy.Phyllanthus spp. induces selective growth inhibition of PC-3 and MeWo human cancer cells through modulation of cell cycle and induction of apoptosis.Pomegranate extracts and cancer prevention: molecular and cellular activities.Small molecule inhibitors of HCV replication from pomegranate Cancer chemoprevention by pomegranate: laboratory and clinical evidence.Greco-arab and islamic herbal-derived anticancer modalities: from tradition to molecular mechanisms.Integrated standardization concept for Angelica botanicals using quantitative NMR Medicinal plants with potential anti-arthritic activity Synergistic effects and related bioactive mechanism of Potentilla fruticosa L. leaves combined with Ginkgo biloba extracts studied with microbial test system (MTS).Role of vitamins, minerals and supplements in the prevention and management of prostate cancer.Polyphenols from green tea and pomegranate for prevention of prostate cancer.Pomegranate exerts chemoprevention of experimentally induced mammary tumorigenesis by suppression of cell proliferation and induction of apoptosis.Ajwa Date (Phoenix dactylifera L.) Extract Inhibits Human Breast Adenocarcinoma (MCF7) Cells In Vitro by Inducing Apoptosis and Cell Cycle Arrest Dietary agents for chemoprevention of prostate cancer.Chemical composition and inhibitory effects of water extract of Henna leaves on reactive oxygen species, DNA scission and proliferation of cancer cells Preventive and prophylactic mechanisms of action of pomegranate bioactive constituents.A Comprehensive Review of Punica granatum (Pomegranate) Properties in Toxicological, Pharmacological, Cellular and Molecular Biology Researches.Pomegranate and its components as alternative treatment for prostate cancer.Nutrition and prostate cancer: an overview.Pomegranate juice and specific components inhibit cell and molecular processes critical for metastasis of breast cancer.Cellular and molecular mechanisms of pomegranate juice-induced anti-metastatic effect on prostate cancer cells.Pomegranate fruit extract impairs invasion and motility in human breast cancer.Colon-available raspberry polyphenols exhibit anti-cancer effects on in vitro models of colon cancer.Pomegranate-mediated chemoprevention of experimental hepatocarcinogenesis involves Nrf2-regulated antioxidant mechanisms.Specific pomegranate juice components as potential inhibitors of prostate cancer metastasis.Diverse Phytochemicals and Bioactivities in the Ancient Fruit and Modern Functional Food Pomegranate (Punica granatum).Pomegranate juice does not impair clearance of oral or intravenous midazolam, a probe for cytochrome P450-3A activity: comparison with grapefruit juice.Punica granatum (Pomegranate) activity in health promotion and cancer prevention.Synergistic Effects of Potentilla fruticosa L. Leaves Combined with Green Tea Polyphenols in a Variety of Oxidation Systems.Antiliperoxidant activity of pomegranate peel extracts on lard.Mechanism of Breast Cancer Preventive Action of Pomegranate: Disruption of Estrogen Receptor and Wnt/β-Catenin Signaling Pathways.Health Benefits of Punicic Acid: A Review

P2860

Q26800877-9FC2988B-E864-4C53-A05C-A6D12DC84AC5 Q26998985-8B2B90E3-8526-45C8-9E76-4288278C90E4 Q27311628-6F56CC74-0644-48AB-B6D2-C16CDA334CD2 Q33553079-9EF70E51-7C63-46AF-95E9-72E01DFA66CF Q33691551-702CCBDF-7A91-454C-8E3F-542E80CCD3BB Q33736926-F76252DE-B033-469E-BA6D-7008D7806DAB Q33794802-67BF076E-26AD-47B0-8C01-62C6603470EC Q34340743-CBF3E719-27A1-4DA6-A17D-A72D42B6F681 Q35607042-8106DAD3-E3B1-4AAC-9A02-96D1B209C30F Q36050621-4B7DB3F5-6907-471E-819E-96C2FDFD5C86 Q36051068-25CD8F7F-963C-4A2D-9427-7DC36C882B2B Q36209166-01B79F24-B396-41B9-B1D2-93901817A58E Q36414920-708E7398-FF81-4B1D-87DE-DFBB80C6BF62 Q36610398-CFDA37B3-6FF8-4512-A4B2-9681DC759A5D Q36668547-56897C27-B3BB-473C-A7BD-CBC44DC73573 Q37114914-2CC1FE74-954F-4D1F-91C2-A9364D5439D4 Q37131601-B2C51581-94FE-4A9D-BD8A-77B966B6A9A9 Q37717054-4720383C-E9FD-4074-9DA0-773BD664E1EE Q38112115-A7F76E5F-2952-485F-9757-05BDFBF67A92 Q38163981-54535474-2E85-4AA0-9202-0D759B0C52D2 Q38243393-4E753836-E873-4CD8-8768-C8A19A4668D9 Q38264784-95675147-8ABA-4A03-8D31-C1466B174C26 Q39259483-E62F1DFB-1F0B-4C87-92CE-1C0355CE3D27 Q39540046-3047E421-63D2-4989-9C80-A88E537C30FE Q39789722-36F3C6B0-595A-43CE-80D9-BC75F52A6C8B Q41865929-AD1721C4-FCE0-477C-91CF-B6F804020C62 Q42036845-2A05DD21-2BC7-4FC9-8A8B-42F4B581707C Q42170228-923941ED-0E90-4825-9359-16AB941D560E Q46457131-B5737E79-0A30-4557-8A55-E6F6277186B2 Q48618446-0EB18603-3512-4227-9F41-AE7A1B6F2F1A Q50022489-B0F79053-DCB2-4D41-8421-DCC698EB3B50 Q50230137-39AF3D19-5C0B-42BA-8281-A6A1943228C5 Q51045697-8CD8A302-DBB4-45B1-B037-156D3845E4D6 Q52666613-C5E3AAC5-4A70-4C13-8BD4-32934F64DAE1 Q56638084-57001880-75FF-4C39-9329-A4C48EB972AC

P2860

Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions.

http://www.wikidata.org/entity/Q33982878

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Possible synergistic prostate ...... iscrete pomegranate fractions.

@ast

Possible synergistic prostate ...... iscrete pomegranate fractions.

@en

type

label

Possible synergistic prostate ...... iscrete pomegranate fractions.

@ast

Possible synergistic prostate ...... iscrete pomegranate fractions.

@en

prefLabel

Possible synergistic prostate ...... iscrete pomegranate fractions.

@ast

Possible synergistic prostate ...... iscrete pomegranate fractions.

@en

P1433

Q33982878-ED3EEB13-F93F-4935-9E15-453CB9C7A2DC

P1476

Q33982878-301D9B37-BBFB-4BBD-9386-6F88E891ABAE

P2093

Q33982878-032F5525-6B59-43FE-9DD8-E10127EC4EC7

Q33982878-233A2ABE-8399-4F47-A532-0306E5BA06BF

Q33982878-4A7CA352-0C14-4997-B765-C08F904EF24E

Q33982878-6AEB5740-CD1B-470D-B30B-1E2E64EB9002

Q33982878-6FFCB057-632E-4B4F-9983-8C2EEDA9E63B

Q33982878-8F7BA930-F5D1-4ABD-803E-338688E07555

Q33982878-9B538E54-0730-405F-A88B-7BA1E334A4C1

Q33982878-B7458028-2DDC-403B-91AB-DECDFE016065

Q33982878-E4FD2897-9BFB-457A-BCCE-ED70FE90FD92

P2888

Q33982878-E4535B9C-4CBD-4E29-87CE-236AE98DF38E

P304

Q33982878-198C116D-E9A4-469C-9034-B35E6933E1F5

P31

Q33982878-60672D05-C14F-44D3-9CFA-69C500BA4A5F

P356

Q33982878-187B64EB-D6D5-46F0-9EA3-A9BC74867DEE

P433

Q33982878-C5A48A3F-A295-4727-AEA1-DE98F3B4FDC7

P478

Q33982878-8FD56DEF-64B4-48C9-B695-237BD7E8B1DD

P577

Q33982878-E4192BA8-5A44-47BD-8CD9-1A87FABB14FB

P6179

Q33982878-FA77E77C-92B2-4F08-91E9-E17CD0A1E9B2

P698

Q33982878-8B10D9DB-136C-4ABD-8B7A-C26B9EDADAC7

P356

B:DRUG.0000047101.02178.07

P1433

Investigational New Drugs

P1476

Possible synergistic prostate ...... iscrete pomegranate fractions.

@en

P2093

Ephraim P Lansky

http://www.w3.org/2001/XMLSchema#string

Huanbiao Mo

http://www.w3.org/2001/XMLSchema#string

Ishak Neeman

http://www.w3.org/2001/XMLSchema#string

Lou Bravo

http://www.w3.org/2001/XMLSchema#string

Moray J Campbell

http://www.w3.org/2001/XMLSchema#string

Neil M Harris

http://www.w3.org/2001/XMLSchema#string

Paul Froom

http://www.w3.org/2001/XMLSchema#string

Weiping Yu

http://www.w3.org/2001/XMLSchema#string

Wenguo Jiang

http://www.w3.org/2001/XMLSchema#string

P2888

b:drug.0000047101.02178.07

P304

11-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1023/B:DRUG.0000047101.02178.07

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1043507034

http://www.w3.org/2001/XMLSchema#string

P698

15528976

http://www.w3.org/2001/XMLSchema#string